Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797285 · ClinicalTrials.gov registry record · NA
Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer and Ulcer Healing, sponsored by ProgenaCare Global.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 3
- Study locations
NCT05797285: Completed NA study of Diabetic Foot Ulcer and Ulcer Healing, sponsored by ProgenaCare Global.
NCT05797285 is a NA study of Diabetic Foot Ulcer and Ulcer Healing that has completed, run by ProgenaCare Global. The registered enrollment target is 26 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05797285, a NA study of Diabetic Foot Ulcer and Ulcer Healing, has completed, sponsored by ProgenaCare Global.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical pilot is to collect patient outcome data on a commercially available, keratin-based skin substitute matrix: ProgenaMatrix®. In this trial, two groups of patients with diabetic foot ulcers (DFUs) will be randomized to receive treatment with ProgenaMatrix applied either weekly or bi-weekly to the target wound. Researchers will compare how weekly or bi-weekly application of ProgenaMatrix affects the healing of DFUs. The primary questions to be answered are: 1. How many patients achieve wound closure in 12 weeks with ProgenaMatrix treatment? And 2. What is the change in wound area during the trial in each group?
Primary Outcome
The proportion of subjects that achieve complete closure of the target wound with each treatment.
Conditions Studied
Interventions
- DEVICE human keratin graft
Study Locations (3)
Florida
- Doctors Research Network - Miami
Maryland
- Foot and Ankle Specialists of the Mid-Atlantic (FASMA) - Frederick
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic (FASMA) - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2023-12-20 |
| Phase | NA |
What the finished NCT05797285 record still lists
NCT05797285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which human keratin graft is the first listed.
NCT05797285 reports a single indexed study location in Florida, Maryland, Virginia.
Frequently Asked Questions
What is clinical trial NCT05797285 about?
NCT05797285 is a clinical study titled "Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers". The goal of this clinical pilot is to collect patient outcome data on a commercially available, keratin-based skin substitute matrix: ProgenaMatrix®. In this trial, two groups of patients with diabetic foot ulcers (DFUs) will be randomized to receive treatment with ProgenaMatrix applied either weekl...
What is the current status of trial NCT05797285?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-02-28. Estimated completion is 2023-12-20.
What conditions does trial NCT05797285 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Ulcer Healing.
What interventions are being tested in trial NCT05797285?
The interventions under investigation include: human keratin graft (DEVICE).
Who is sponsoring clinical trial NCT05797285?
This trial is sponsored by ProgenaCare Global, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05797285 being conducted?
This trial has 3 study locations across Florida, Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05797285's enrollment target sits among peer trials
26 58th of 67 higher than 10 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI